[Clonal expansion of TCR Vbeta subfamily T cells induced by bcr3-abl2 peptide]

Zhonghua Xue Ye Xue Za Zhi. 2004 Feb;25(2):95-9.
[Article in Chinese]

Abstract

Objective: To investigate the clonal expansion of T cell receptor (TCR) Vbeta subfamily T cells from cord blood induced by bcr3-abl2 peptide in vitro.

Methods: T cells from 3 units of cord blood were amplified by anti-CD(3) monoclonal antibody (McAb) and IL-2 with or without synthetic b3a2 peptide. T cell specific cytotoxicity was analyzed by lactate dehydrogenase (LDH) assay, TCR Vbeta subfamilies by using reverse transcriptase-polymerase chain reaction (RT-PCR) and genescan technique.

Results: bcr3-abl2 peptide specific cytotoxicity T cells were successfully induced from the 3 units of cord blood by synthetic b3a2 peptide. Compared with that in CD(3) McAb induced cells, distribution pattern of TCR Vbeta repertoire was different in T cells induced with b3a2 peptide. Oligoclonal and oligoclonal tendency TCR Vbeta subfamily T cells could be identified in cord blood T cells induced by b3a2 peptide in 1 or 2 weeks, whereas those induced by anti-CD(3) McAb and IL-2 were mostly polyclonal.

Conclusion: The cytotoxicity T cells with anti-CML specificity could be induced by b3a2 peptide. The specific anti-CML cytotoxicity may be derived from the clonal expansion TCR Vbeta subfamily T cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / immunology
  • CD3 Complex / immunology
  • Fusion Proteins, bcr-abl / pharmacology*
  • Genes, T-Cell Receptor beta*
  • Humans
  • Interleukin-2 / pharmacology
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / immunology*
  • T-Lymphocytes, Cytotoxic / immunology*

Substances

  • Antibodies, Monoclonal
  • CD3 Complex
  • Interleukin-2
  • Fusion Proteins, bcr-abl